Dr Melanie Lockett, Consultant Physician and Gastroenterologist
Dr Melanie Lockett
Consultant Physician and Gastroenterologist
Dr Melanie Lockett BSc MB BS MD FRCP
Consultant Physician and Gastroenterologist
Dr Melanie Lockett
Consultant Physician and Gastroenterologist BSc MB BS MD FRCP
Areas of expertise
- Colonoscopy
- Bowel cancer screening
- Inflammatory bowel disease
- Nutrition
- General gastroenterology
Recommendations for Dr Lockett
These recommendations are for information purposes only. Doctors providing recommendations do so in good faith and are not responsible for clinical outcomes.
Recommended by:
Make an appointment
Address
-
Spire Bristol Hospital
The Glen, Redland Hill, Durdham Down, BS6 6UT
-
Telephone consultation
Virtual
North Bristol NHS Trust
Southmead Way, Southmead Hospital, Bristol, BS10 5NB
About Dr Melanie Lockett
GMC number: 4096728
Year qualified: 1994
Place of primary qualification: University of London
Dr Melanie Lockett has been a Consultant Physician and Gastroenterologist at Frenchay Hospital, North Bristol NHS Trust since 2005. She has now set up two multidisciplinary nutrition teams and is currently the lead gastroenterologist for nutrition in North Bristol NHS Trust (NBT). She is the lead physician for intestinal bowel disease (IBD) in NBT and is experienced in the management of complex IBD. She believes in patient education and self-management and a multidisciplinary team approach. She is developing an IBD database and is experienced in the use of biological agents. She can offer dye-spray colonoscopy surveillance for extensive colitis.
Dr Lockett did her general medical and gastroenterological training on the prestigious North West Thames rotation. She was trained in colonoscopy at the Wolfson Unit for Endoscopy, St. Mark's hospital. St. Mark's hospital is the UK's only specialist hospital for colorectal disease and the Wolfson unit is a national colonoscopy training centre and an accredited bowel cancer screening centre. She is now teaching on the South West colonoscopy training courses. Her research 'Hyperplastic polyposis, serrated polyps and the serrated colorectal cancer pathway' was supervised by Professor Wendy Atkin and resulted in an MD from the University of London. During her research years, she developed an interest in familial colorectal cancer. She spent four years working in the intestinal failure unit at St. Mark's hospital, one of only two units in the UK.
Areas of expertise
- Abdominal distension
- Abdominal pain
- Abnormal liver function
- Achalasia
- Alcoholic liver disease
- Anorexia
- Ascites
- Barrett’s oesophagus
- Bile acid malabsorption
- Bloating
- Bowel cancer screening
- Chronic pancreatitis
- Cirrhosis
- Coeliac disease
- Colitis
- Collagenous colitis
- Colonic polyps
- Colonoscopy
- Constipation
- Crohn’s disease
- Diarrhoea
- Difficulty swallowing
- Dysphagia
- Endoscopy
- Faecal urgency
- Familial colorectal cancer
- Family history of bowel or colon cancer
- Fatty liver
- Fatty stools
- Flexible sigmoidoscopy
- Gastro-oesophageal reflux disease
- Gastroscopy
- General gastroenterology
- General hepatology
- General liver disorders
- General pancreatic disorders
- Haematemesis
- Heartburn
- Helicobacter pylori
- Hepatitis
- Hiatus hernia
- Incomplete rectal emptying
- Incontinence
- Indigestion
- Inflammatory bowel disease
- Iron deficiency anaemia
- Irritable bowel syndrome
- Liver disease
- Malabsorption
- Melaena
- Microscopic colitis
- Nash
- Nausea
- Nutrition
- Oesophageal stricture
- Oesophagogastro duodenoscopy (OGD)
- Pancreatology
- Peptic ulcer disease
- Poor appetite
- Portal hypertension
- Proctoscopy
- Rectal bleeding
- Rectal dissatisfaction
- Reflux
- Regurgitation
- Short bowel syndrome
- Sickness
- Small intestinal bacterial overgrowth
- Steatorrhoea
- Tenesmus
- Ulcerative colitis
- Undernutrition
- Varices
- Vomiting
- Vomiting blood
- Weight loss
Professional memberships
Articles by Dr Melanie Lockett
Probiotic VSL#3 prevents antibiotic-associated diarrhoea in a double-blind, randomized, placebo-controlled clinical trial
Clinical features and HLA association of 5-aminosalicylate (5-ASA)-induced nephrotoxicity in inflammatory bowel disease